期刊文献+

精神分裂症患者一级亲属血清C反应蛋白水平及其相关因素研究 被引量:2

Study on the levels of C-reactive protein of first-degree relatives of schizophrenia patients and its related factors
下载PDF
导出
摘要 目的观察精神分裂症患者一级亲属血清C反应蛋白(C-reactive protein,CRP)水平表达,分析其血清CRP水平变化可能的相关因素。方法选择医院住院治疗的精神分裂症患者100例及其一级亲属175例作为研究对象,将精神分裂症者作为精神分裂症组,将一级亲属作为一级亲属组,并选择同期医院接受全身体检证实为身体健康的200名人群作为健康对照组。对全部调查人员均测定血清CRP水平,一级亲属接受症状自评量表(symptom checklist,SCL-90)、精神分裂症认知功能成套测验(MATRICS consensus cognitive battery,MCCB)、阳性和阴性症状量表(positive and negative symptom scale,PANSS)等评分测试评定。比较3组血清CRP水平表达,比较一级亲属与健康对照组SCL-90评分;对比一级亲属不同性别、年龄、心理健康状况、认知功能、症状严重程度等情况下的CRP水平表达,经线性回归分析一级亲属血清CRP水平异常可能的相关因素。结果3组受检者中,精神分裂症组患者血清CRP水平最高,后由高至低依次为一级家属组、健康对照组,组间比较,差异有统计学意义(P<0.05);较健康对照组,一级亲属组强迫症状、躯体化、人际关系敏感、焦虑、抑郁、敌对、恐惧、偏执、精神病性得分及总得分均高于健康对照组,差异有统计学意义(P<0.05)。经线性回归分析检验结果显示,心理健康状态不佳、认知功能低下及中重度症状均可能是影响精神分裂症一级亲属血清CRP水平的相关因素(P<0.05)。结论精神分裂症患者一级亲属血清CRP水平呈高表达,可能与一级亲属不良心理健康状况、认知功能低下、合并一定程度的精神分裂症症状等因素有关,对于家族有精神分裂症治疗史的人群,若精神分裂症患者是其一级亲属,应注意血清CRP水平表达的变化,若发现血清CRP呈异常高表达,应及时干预,以减少精神分裂症的发生。 Objective To observe the expression of C-reactive protein(CRP)of first-degree relatives(FDR)of schizophrenia patients,and to analyze the related factors of changes of serum CRP.Methods In total,100 schizophrenia patients who were hospitalized and 175 FDR were selected as research subjects.Patients with schizophrenia were taken as schizophrenia group,and the FDR served as FDR group.Another 200 healthy people who underwent physical examination in the hospital were selected as healthy control group.The serum CRP levels of all subjects were detected,and FDR was assessed by the symptom checklist(SCL-90),MATRICS consensus cognitive battery(MCCB)and positive and negative symptom scale(PANSS).The expressions of serum CRP levels were compared among the three groups,and the SCL-90 scores of FDR group and healthy control group were compared.The expression of CRP levels of FDR with different gender,age,mental health status,cognitive function,severity of symptoms were compared,and linear regression analysis was used to analyze the potential factors related to abnormal CRP levels in FDR.Results Among three groups,the serum CRP level of schizophrenia group was the highest,followed by FDR group and healthy control group,and the difference was statistically significant between groups(P<0.05).The compulsive symptoms,somatization,interpersonal sensitivity,anxiety,depression,hostility,fear,paranoia,psychotic scores and total score in FDR group were higher than those in healthy control group,suggesting significant differences(P<0.05).The results of linear regression analysis showed that poor mental health,poor cognitive impairment and moderate to severe symptoms might be related factors affecting serum CRP levels in FDR of patients with schizophrenia(P<0.05).Conclusion The serum CRP level of FDR of patients with schizophrenia is highly expressed,which may be related to the poor mental health status,poor cognitive impairment,and combined symptoms of FDR with certain degree of schizophrenia.For people with a family history of schizophrenia treatment,if the schizophrenia patient is FDR,attention should be paid to the changes of expression of serum CRP levels.Serum CRP that is found to be abnormally high should be promptly intervened to reduce the incidence of schizophrenia.
作者 张顺 李娜 梁静 王丽萍 马文有 ZHANG Shun;LI Na;LIANG Jing;WANG Li-ping;MA Wen-you(Department of Psychosomatic Laboratory, Kailuan Mental Health Centre of Tangshan City, Hebei Province, Tangshan 063000, China;The Fourth Inpatient Ward, Kailuan Mental Health Centre of Tangshan City, Hebei Province, Tangshan 063000, China;Department of Neurosurgery, Kailuan Mental Health Centre of Tangshan City, Hebei Province, Tangshan 063000, China;Department of Office, Kailuan Mental Health Centre of Tangshan City, Hebei Province, Tangshan 063000, China)
出处 《河北医科大学学报》 CAS 2022年第4期433-438,共6页 Journal of Hebei Medical University
基金 河北省医学科学科技成果推广课题(20181460)。
关键词 精神分裂症 家庭 C反应蛋白质 schizophrenia family C-reactive protein
  • 相关文献

参考文献8

二级参考文献57

  • 1王赞利,高成阁,纪术茂.缓解期神经症患者人格特征研究[J].中华临床医学杂志,2007,8(2):1-3. 被引量:1
  • 2Yamashita C, Mizuno M, Nemoto T, et al. Social cognitive problem-solving in schizophrenia: associations with fluency and verbal memory. Psychiatry Res, 2005, 134 : 123-129.
  • 3Penades R, Boget T, Catalon R, et al. Cognitive mechanisms, psychosocial functioning, and neurocognitive rehabilitation in schizophrenia. Schizophr Res, 2003,63:219-227.
  • 4Marder SR, Fenton W. Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. Schizophr Res, 2004, 72:5-9.
  • 5Kern RS, Green MF, Nuechterlein KH, et al. NIMH-MATRICS survey on assessment of neurocognition in schizophrenia. Schizophr Res, 2004,72:11-19.
  • 6Green MF, Nueehterlein KH. The MATRICS initiative: developing a consensus cognitive battery for clinical trials. Schizophr Res, 2004, 72 : 1-3.
  • 7Green MF, Nuechterlein KH, Gold JM, et al. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry, 2004,56:301-307.
  • 8Nuechterlein KH, Barch DM, Gold JM, et al. Identification of separable cognitive factors in schizophrenia. Schizophr Res, 2004, 72:29-39.
  • 9Nuechterlein KH, Green MF, Kern RS, et al. The MATRICS Consensus Cognitive Battery, part 1 : test selection, reliability, and validity. Am J Psychiatry, 2008,165:203-313.
  • 10Kern RS, Nuechterlein KH, Green MF, et al. The MATRICS Consensus Cognitive Battery, part 2 : eo-norming and standardization. Am J Psychiatry, 2008,165:214-220.

共引文献1105

同被引文献18

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部